{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:21Z","timestamp":1707524361059},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,20]]},"DOI":"10.7759\/cureus.19769","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T13:06:50Z","timestamp":1637413610000},"source":"Crossref","is-referenced-by-count":2,"title":["Cisplatin-Induced Bradycardia: A Silent Risk Observed in Two Different Clinical Cases"],"prefix":"10.7759","author":[{"given":"Sameen","family":"Bin Naeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqib Ullah","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Masood Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jlac.18440510102","article-title":"About the effect of ammonia on platinum chloride (Article in German)","volume":"51","author":"Peyrone M","year":"1844","unstructured":"Peyrone M. About the effect of ammonia on platinum chloride (Article in German). Justus Liebigs Ann Chem. 1844, 51:1-29. 10.1002\/jlac.18440510102","journal-title":"Justus Liebigs Ann Chem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland L","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007, 7:573-84. 10.1038\/nrc2167","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari S","year":"2014","unstructured":"Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014, 740:364-78. 10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12210","article-title":"Cisplatin for testicular germ cell tumors: a rapid review","volume":"9","author":"Hu Z","year":"2016","unstructured":"Hu Z, Yu J, Gui G, et al.. Cisplatin for testicular germ cell tumors: a rapid review. J Evid Based Med. 2016, 9:144-51. 10.1111\/jebm.12210","journal-title":"J Evid Based Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea AM","year":"2011","unstructured":"Florea AM, B\u00fcsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011, 3:1351-71. 10.3390\/cancers3011351","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013807","article-title":"Cisplatin-induced cardiotoxicity with midrange ejection fraction: a case report and review of the literature","volume":"97","author":"Hu Y","year":"2018","unstructured":"Hu Y, Sun B, Zhao B, Mei D, Gu Q, Tian Z. Cisplatin-induced cardiotoxicity with midrange ejection fraction: a case report and review of the literature. Medicine (Baltimore). 2018, 97:e13807. 10.1097\/MD.0000000000013807","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880715)62:2<266::aid-cncr2820620207>3.0.co;2-y","article-title":"Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil","volume":"62","author":"Jakubowski AA","year":"1988","unstructured":"Jakubowski AA, Kemeny N. Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer. 1988, 62:266-9. 10.1002\/1097-0142(19880715)62:2&lt;266::aid-cncr2820620207&gt;3.0.co;2-y","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.10.027","article-title":"Cisplatin-induced bradycardia: cardiac toxicity or cardiac hypersensitivity and Kounis syndrome?","volume":"202","author":"Kounis NG","year":"2016","unstructured":"Kounis NG, Cervellin G, Lippi G. Cisplatin-induced bradycardia: cardiac toxicity or cardiac hypersensitivity and Kounis syndrome?. Int J Cardiol. 2016, 202:817-8. 10.1016\/j.ijcard.2015.10.027","journal-title":"Int J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/106002808301701207","article-title":"Cisplatin-induced bradycardia","volume":"17","author":"Schlaeffer F","year":"1983","unstructured":"Schlaeffer F, Tovi F, Leiberman A. Cisplatin-induced bradycardia. Drug Intell Clin Pharm. 1983, 17:899-901. 10.1177\/106002808301701207","journal-title":"Drug Intell Clin Pharm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005443","article-title":"Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies","volume":"10","author":"Buza V","year":"2017","unstructured":"Buza V, Rajagopalan B, Curtis AB. Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies. Circ Arrhythm Electrophysiol. 2017, 10:005443. 10.1161\/CIRCEP.117.005443","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4195","article-title":"Bradycardia as a rare symptom of cisplatin cardiotoxicity: a case report","volume":"11","author":"Kucharz J","year":"2016","unstructured":"Kucharz J, Michalowska-Kaczmarczyk A, Zygulska AL, Wojtak J, Pawlik W, Herman RM, Krzemieniecki K. Bradycardia as a rare symptom of cisplatin cardiotoxicity: a case report. Oncol Lett. 2016, 11:2297-9. 10.3892\/ol.2016.4195","journal-title":"Oncol Lett"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_26_18","article-title":"A rare entity: recurrent cisplatin-induced bradycardia","volume":"16","author":"Sagcan F","year":"2020","unstructured":"Sagcan F, Citak EC, Karpuz D, Alakaya M. A rare entity: recurrent cisplatin-induced bradycardia. J Cancer Res Ther. 2020, 16:699-700. 10.4103\/jcrt.JCRT_26_18","journal-title":"J Cancer Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.01.013","article-title":"Cisplatin induced bradycardia","volume":"182","author":"Darling HS","year":"2015","unstructured":"Darling HS. Cisplatin induced bradycardia. Int J Cardiol. 2015, 182:304-6. 10.1016\/j.ijcard.2015.01.013","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh ET","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009, 53:2231-47. 10.1016\/j.jacc.2009.02.050","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi MT","year":"2000","unstructured":"Meinardi MT, Gietema JA, van der Graaf WT, et al.. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000, 18:1725-32. 10.1200\/JCO.2000.18.8.1725","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.09.085","article-title":"Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies","volume":"650","author":"El-Awady el-SE","year":"2011","unstructured":"El-Awady el-SE, Moustafa YM, Abo-Elmatty DM, Radwan A. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol. 2011, 650:335-41. 10.1016\/j.ejphar.2010.09.085","journal-title":"Eur J Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77508-cisplatin-induced-bradycardia-a-silent-risk-observed-in-two-different-clinical-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:37Z","timestamp":1707507037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77508-cisplatin-induced-bradycardia-a-silent-risk-observed-in-two-different-clinical-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.19769","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}